Nav: Home

Study links sulfide-producing bacteria and colon cancer in African-Americans

March 15, 2017

CHAMPAIGN, Ill. -- A new study reveals that African-Americans have measurable differences in the number and type of bacteria that live in the colon - and those differences are related to their higher-than-average colon cancer risk.

The study, reported in the journal Gut, looked at colonic tissue biopsies from 197 African-Americans and 132 non-Hispanic whites collected over a two-year period ending in 2012. The researchers amplified microbial DNA from the samples, then looked at the abundance of various types of microbes.

The study found that African-Americans have more sulfide-producing bacteria in their colon than non-Hispanic whites in the U.S. do. Although these microbes are a normal part of the gut ecosystem, an overabundance of sulfide in the colon can lead to inflammation and can damage DNA, said University of Illinois animal sciences professor Rex Gaskins, who led the new research with Nathan Ellis, who was at the University of Illinois at Chicago at the time of the study. Ellis is the scientific director of the Cancer Biology Research Program at the University of Arizona Cancer Center in Tucson.

"We found that African-Americans have an increased abundance of bacteria that make hydrogen sulfide, which we demonstrated more than a decade ago to be a potent genotoxin," Gaskins said.

The study also revealed that Bilophila wadsworthia, a bacterium that produces hydrogen sulfide from the amino acid taurine, was significantly more abundant in African-Americans with colon cancer than in their healthy counterparts.

"These bacteria are using nutrients associated with an animal-based diet," Gaskins said.

The relationship between B. wadsworthia abundance and colon cancer risk did not hold true for non-Hispanic whites, however.

Most cases of colorectal cancer - about 85 to 90 percent - are sporadic, rather than familial, Gaskins said. There may be a genetic element, but environmental factors like exposure to pollutants or dietary components also are required to spur the onset of cancer.

"You have to have a genotoxin to have colon cancer," Gaskins said. "And sulfide is a genotoxin."

African-Americans have significantly higher incidence of colon cancer than other Americans. In 2013, there were 33.5 colon cancer cases per 100,000 African-Americans, compared with 26.8 per 100,000 whites.

Explaining these disparities has not been easy. Native Africans have dramatically lower colon cancer rates than African-Americans, suggesting that environmental factors, including dietary habits, are a key to the problem, along with genetics.

A 2014 study on which Gaskins was a senior co-author found that switching rural South African Zulus who normally ate a low-fat, high-fiber diet to a diet with a lot of meat and animal fat led to increases in sulfide-producing bacteria in their colon. This change took less than two weeks, the researchers found.

Scientists already knew that a diet high in red meat and animal fat was associated with an increased risk of developing colon cancer, Gaskins said.

"We are now beginning to connect the dots between these dietary factors and one's risk of developing colon cancer risk," he said. "Our research adds to the evidence that the microbes that inhabit the colon are part of the equation and should not be overlooked."

Gaskins also is affiliated with the Carl R. Woese Institute for Genomic Biology.
The National Cancer Institute and the American Cancer Society supported this research.

Editor's notes: To reach Rex Gaskins, call 217-244-3165; email

The paper "Race-dependent association of sulfidogenic bacteria with colorectal cancer" is available online and from the U. of I. News Bureau.

DOI: 10.1136/gutjnl-2016-313321

University of Illinois at Urbana-Champaign

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...